Iron deficiency promotes aortic medial degeneration via destructing cytoskeleton of vascular smooth muscle cells.


Journal

Clinical and translational medicine
ISSN: 2001-1326
Titre abrégé: Clin Transl Med
Pays: United States
ID NLM: 101597971

Informations de publication

Date de publication:
01 2021
Historique:
entrez: 19 1 2021
pubmed: 20 1 2021
medline: 20 1 2021
Statut: ppublish

Résumé

Aortic dissection (AD) and aortic aneurysm (AA) are critical illnesses with an unclear pathogenetic mechanism that seriously threaten human life. Aortic medial degeneration (AMD) is the main pathological feature of AD and AA. Diseases of iron metabolism can cause a variety of physiological dysfunctions. In this study, we aimed to clarify the state of iron metabolism in patients with AD and AA, and to explore the effect of iron metabolism on AMD. A total of 200 patients with AD or AA, and 60 patients with hypertension were included in the study. Blood samples were drawn immediately when patients were admitted to the hospital. Aortic specimens from patients with Stanford type A AD were obtained at the time of surgery. The status of iron metabolism in the circulation and the aortic wall was analyzed. In addition, apolipoprotein E knockout mice were fed chow with a different iron content, and angiotensin II (Ang II) was used to induce AMD. Furthermore, transferrin receptor 1 knockout (TFR1-/-) mice were used to study the effects of iron deficiency (ID) on aortic development, to observe the effects of different iron metabolism status on the formation of AMD in mice, and to explore the cytoskeleton of vascular smooth muscle cells (VSMCs) under different iron metabolism. Patients with AMD were iron deficient. ID is associated with the development of AMD in hypertensive patients. Iron-deficient feeding combined with Ang II pumping promoted the formation of AMD and significantly shortened the survival time of mice. ID significantly impaired the cytoskeleton of VSMCs. Our results highlighted that ID was associated with the formation of AMD in patients with hypertension. In this study, we identified a novel mechanism behind VSMCs dysfunction that was induced by ID, thereby suggesting iron homeostasis as a future precaution in patients with hypertension based on its important role in the maintenance of VSMC function.

Sections du résumé

BACKGROUND
Aortic dissection (AD) and aortic aneurysm (AA) are critical illnesses with an unclear pathogenetic mechanism that seriously threaten human life. Aortic medial degeneration (AMD) is the main pathological feature of AD and AA. Diseases of iron metabolism can cause a variety of physiological dysfunctions. In this study, we aimed to clarify the state of iron metabolism in patients with AD and AA, and to explore the effect of iron metabolism on AMD.
METHODS
A total of 200 patients with AD or AA, and 60 patients with hypertension were included in the study. Blood samples were drawn immediately when patients were admitted to the hospital. Aortic specimens from patients with Stanford type A AD were obtained at the time of surgery. The status of iron metabolism in the circulation and the aortic wall was analyzed. In addition, apolipoprotein E knockout mice were fed chow with a different iron content, and angiotensin II (Ang II) was used to induce AMD. Furthermore, transferrin receptor 1 knockout (TFR1-/-) mice were used to study the effects of iron deficiency (ID) on aortic development, to observe the effects of different iron metabolism status on the formation of AMD in mice, and to explore the cytoskeleton of vascular smooth muscle cells (VSMCs) under different iron metabolism.
RESULTS
Patients with AMD were iron deficient. ID is associated with the development of AMD in hypertensive patients. Iron-deficient feeding combined with Ang II pumping promoted the formation of AMD and significantly shortened the survival time of mice. ID significantly impaired the cytoskeleton of VSMCs.
CONCLUSIONS
Our results highlighted that ID was associated with the formation of AMD in patients with hypertension. In this study, we identified a novel mechanism behind VSMCs dysfunction that was induced by ID, thereby suggesting iron homeostasis as a future precaution in patients with hypertension based on its important role in the maintenance of VSMC function.

Identifiants

pubmed: 33463069
doi: 10.1002/ctm2.276
pmc: PMC7805404
doi:

Substances chimiques

Iron E1UOL152H7

Types de publication

Journal Article

Langues

eng

Pagination

e276

Informations de copyright

© 2021 The Authors. Clinical and Translational Medicine published by John Wiley & Sons Australia, Ltd on behalf of Shanghai Institute of Clinical Bioinformatics.

Références

Nat Cell Biol. 2016 Aug;18(8):823-32
pubmed: 27428307
Angiology. 2007 Apr-May;58(2):191-5
pubmed: 17495268
J Nippon Med Sch. 2017;84(4):148-159
pubmed: 28978894
Hypertension. 2015 Feb;65(2):362-9
pubmed: 25403607
Transpl Int. 2014 Nov;27(11):1109-17
pubmed: 24964028
J Cardiovasc Pharmacol. 2017 May;69(5):248-263
pubmed: 28328747
J Cardiovasc Surg (Torino). 2017 Apr;58(2):238-251
pubmed: 28124516
Medicine (Baltimore). 2015 Sep;94(38):e1591
pubmed: 26402822
J Hypertens. 2012 Feb;30(2):440-3
pubmed: 22179093
J Am Coll Cardiol. 2018 May 15;71(19):e127-e248
pubmed: 29146535
Annu Rev Physiol. 2007;69:69-85
pubmed: 17014365
Thromb Haemost. 2014 Jul 3;112(1):87-95
pubmed: 24599423
Circulation. 2018 Oct 9;138(15):1551-1568
pubmed: 29669788
Curr Opin Cell Biol. 2013 Dec;25(6):724-9
pubmed: 23890700
Card Fail Rev. 2018 May;4(1):28-32
pubmed: 29892473
Ann Vasc Surg. 2017 Apr;40:262-273
pubmed: 28167124
Atherosclerosis. 2016 Aug;251:19-24
pubmed: 27235969
J Nutr. 2016 Jan;146(1):30-7
pubmed: 26661838
Mayo Clin Proc. 2009 May;84(5):465-81
pubmed: 19411444
Arterioscler Thromb Vasc Biol. 2015 Jun;35(6):1507-14
pubmed: 25882069
Biol Trace Elem Res. 2016 Feb;169(2):159-63
pubmed: 26152852
Anesth Analg. 2010 Aug;111(2):279-315
pubmed: 20664093
Circ Res. 2016 Feb 19;118(4):692-702
pubmed: 26892967
ESC Heart Fail. 2018 Oct;5(5):764-771
pubmed: 30073785
Cell Signal. 2018 Dec;52:48-64
pubmed: 30172025
Am J Physiol Gastrointest Liver Physiol. 2006 Feb;290(2):G199-203
pubmed: 16407589
N Engl J Med. 1999 Dec 23;341(26):1986-95
pubmed: 10607817
J Nutr. 1989 Jan;119(1):40-7
pubmed: 2492336
Ann N Y Acad Sci. 2016 Mar;1368(1):149-61
pubmed: 26890363
Cold Spring Harb Perspect Biol. 2018 Oct 1;10(10):
pubmed: 28851747
Acta Paediatr Scand Suppl. 1989;361:78-85
pubmed: 2485589
J Trace Elem Med Biol. 2009;23(2):100-6
pubmed: 19398057
J Biol Chem. 2017 Aug 4;292(31):12727-12734
pubmed: 28615456
Ageing Res Rev. 2014 Nov;18:132-47
pubmed: 25311590
Appl Immunohistochem Mol Morphol. 2007 Jun;15(2):124-33
pubmed: 17525622
Physiol Rev. 2017 Oct 1;97(4):1555-1617
pubmed: 28954852

Auteurs

Bowen Li (B)

Department of Cardiovascular Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
Cardiovascular Surgery Laboratory, Renmin Hospital of Wuhan University, Wuhan, China.
Central Laboratory, Renmin Hospital of Wuhan University, Wuhan, China.

Zhiwei Wang (Z)

Department of Cardiovascular Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
Cardiovascular Surgery Laboratory, Renmin Hospital of Wuhan University, Wuhan, China.

Junmou Hong (J)

Department of Cardiovascular Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
Cardiovascular Surgery Laboratory, Renmin Hospital of Wuhan University, Wuhan, China.
Central Laboratory, Renmin Hospital of Wuhan University, Wuhan, China.

Yanjia Che (Y)

Department of Cardiovascular Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
Cardiovascular Surgery Laboratory, Renmin Hospital of Wuhan University, Wuhan, China.
Central Laboratory, Renmin Hospital of Wuhan University, Wuhan, China.

Ruoshi Chen (R)

Department of Cardiovascular Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
Cardiovascular Surgery Laboratory, Renmin Hospital of Wuhan University, Wuhan, China.
Central Laboratory, Renmin Hospital of Wuhan University, Wuhan, China.

Zhipeng Hu (Z)

Department of Cardiovascular Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
Cardiovascular Surgery Laboratory, Renmin Hospital of Wuhan University, Wuhan, China.

Xiaoping Hu (X)

Department of Cardiovascular Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
Cardiovascular Surgery Laboratory, Renmin Hospital of Wuhan University, Wuhan, China.

Qi Wu (Q)

Department of Cardiovascular Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
Cardiovascular Surgery Laboratory, Renmin Hospital of Wuhan University, Wuhan, China.
Central Laboratory, Renmin Hospital of Wuhan University, Wuhan, China.

Junxia Hu (J)

Department of Cardiovascular Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
Cardiovascular Surgery Laboratory, Renmin Hospital of Wuhan University, Wuhan, China.
Central Laboratory, Renmin Hospital of Wuhan University, Wuhan, China.

Min Zhang (M)

Department of Cardiovascular Surgery, Renmin Hospital of Wuhan University, Wuhan, China.
Cardiovascular Surgery Laboratory, Renmin Hospital of Wuhan University, Wuhan, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH